breast cancer
The Natural History of Rejecting Surgery in Breast Cancer
Few decisions in oncology carry as much emotional weight as the choice to decline surgery for an operable breast cancer.
Yoon Hang Kim MD
Board certified preventive medicine physician. University of Arizona fellowship grad. 20+ years prescribing LDN for chronic pain, autoimmune conditions & complex cases. Author. International speaker. Helping patients find answers.
Understanding Your Lab Results: IgA, Tryptase, and MCAS
Why a normal tryptase does not rule out Mast Cell Activation Syndrome — and why IgA is a separate question Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician If your recent lab work showed an elevated IgA level and a normal tryptase, you may
Integrative Oncology
Evaluating Surgical and Integrative Oncology Options in Early-Stage Breast Carcinoma with Favorable Histology and Multiple Lesions
A Case-Based Review of Attributable Benefit, Attributable Risk, and the Role of Integrative Strategies Alongside Definitive Treatment Yoon Hang Kim, MD, MPH • Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction When a client presents with a new diagnosis of early-stage breast carcinoma, two sets of
Chapter 14 Neuroinflammation and Emotional Effects
CHAPTER 14 Neuroinflammation and Emotional Effects Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician ABSTRACT Low-dose naltrexone (LDN) is widely prescribed for chronic pain and autoimmune conditions, but its effects on mood, cognition, and emotional regulation remain underrecognized in clinical practice. This
ivermectin
The "Makis Protocol": An Informational Review
What is publicly circulated, what has actually been published, and what remains unknown Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Disclosure and position. Dr. Kim does not endorse this protocol and does not present it as an evidence-supported cancer treatment. In
ldn
One Medication, Three Conditions: Why LDN Is Not a Silver Bullet for Long COVID, ME/CFS, and MCAS
Endorphin Depletion, Immune Dysregulation, and the Limits of Pharmacological Optimism Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction: The Allure of a Universal Solution It is tempting to look at Low Dose Naltrexone (LDN) and see a single medication capable of addressing
LDN Prolactin
Low-Dose Naltrexone and Prolactin:What Clinicians Should Know About an Emerging Question
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician www.directintegrativecare.com Introduction As low-dose naltrexone (LDN) prescribing grows across integrative, functional, and conventional medicine settings, clinicians are occasionally encountering an unexpected laboratory finding: a mildly elevated serum prolactin in a client taking
LDN, MCAS, and Why Individualized Dosing Matters
LDN, MCAS, and Why Individualized Dosing Matters A Clinical Educator's Perspective on Low-Dose Naltrexone in Complex Immune-Mediated Illness Yoon Hang Kim, MD, MPH Introduction Low-dose naltrexone (LDN) is frequently discussed as though a standard dose exists, a predictable response can be expected, and the path
The Way and The World
THE WAY AND THE WORD ——— Thy Will Be Done A Physician's Journey into Integrative Medicine
THE WAY AND THE WORD ——— Thy Will Be Done A Physician's Journey into Integrative Medicine Yoon Hang "John" Kim, MD PREFACE "I am the way, the truth, and the life." — John 14:6 "The Tao that can be told is not the eternal
Sudden Double Vision After a Flight: Why It's Urgent and What to Do Next
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician You're on a flight home. Everything is routine — and then, without warning, you start seeing two of everything. The images overlap, shift apart, and the world refuses to come into focus. Maybe it
MCAS
The Layered Approach to Mast Cell Activation Syndrome: Integrating Dr. Afrin’s Framework with Functional Medicine Therapeutics
www.directintegrativecare.com A Clinical Chapter on Trigger Avoidance, Anaphylaxis Preparedness, Antihistamines, Stabilizers, Antileukotrienes, Omalizumab, LDN, Quercetin, Luteolin, and Methylene Blue in a Stepwise Model Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Abstract Mast Cell Activation Syndrome (MCAS) is a multi-system
The Layered Approach to Mast Cell Activation Syndrome: Integrating Dr. Afrin’s Framework with Functional Medicine Therapeutics
www.directintegrativecare.com A Clinical Chapter on Trigger Avoidance, Anaphylaxis Preparedness, Antihistamines, Stabilizers, Antileukotrienes, Omalizumab, LDN, Quercetin, Luteolin, and Methylene Blue in a Stepwise Model Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Abstract Mast Cell Activation Syndrome (MCAS) is a multi-system